Search Results 381-390 of 16423 for HMB loading phase

  1. Dual BET And CBP/p300 Inhibitor In Patients With Targeted Advanced Solid Tumors And Hematological Malignancies - Mayo Clinic

    In the later phase (phase ... There are also less common very early (phase 0) and later (phase 4) phases. ... load within 6 months are eligible for this trial.

  2. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  3. Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) In The Treatment Of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). - Mayo Clinic

    About this study. A global multicenter, randomized, double-blind, placebo-controlled, pivotal phase III study. To evaluate overall survival (OS) of ...

  4. Shear Wave Elastograph and Contrast Enhanced Ultrasound for the Treatment of Lymphedema - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  5. Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in Treatment-Naïve HCV Genotype 1-Infected Adults With Chronic Kidney Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction - Mayo Clinic

    This phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with ...

  7. A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  8. A Study to Evaluate the Use of Pharmacogenomics in the Perioperative Period to Guide Drug Therapy in Patients Undergoing Total Knee Arthroscopy - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  9. Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma - Mayo Clinic

    This randomized phase II trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing sarcoma ...

  10. Medical Research & Education - Mayo Clinic News Network

    Children's Center · Topics · Terms and Conditions · Privacy Policy; Manage Cookies. © . Mayo Clinic News Network. All Rights Reserved. Loading... Loading...